Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

DNase1: No Association with Crohn's Disease in a New Zealand Population.

Morgan AR, Lam WJ, Han DY, Fraser AG, Ferguson LR.

ISRN Gastroenterol. 2012;2012:826323. doi: 10.5402/2012/826323. Epub 2012 Jun 4.

2.

Metallothionein genes: no association with Crohn's disease in a New Zealand population.

Morgan AR, Fraser AG, Ferguson LR.

J Negat Results Biomed. 2012 Jan 28;11:8. doi: 10.1186/1477-5751-11-8.

3.

Association Analysis of ULK1 with Crohn's Disease in a New Zealand Population.

Morgan AR, Lam WJ, Han DY, Fraser AG, Ferguson LR.

Gastroenterol Res Pract. 2012;2012:715309. doi: 10.1155/2012/715309. Epub 2012 Mar 20.

4.

The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn's disease susceptibility in a New Zealand population.

Wang AH, Lam WJ, Han DY, Ding Y, Hu R, Fraser AG, Ferguson LR, Morgan AR.

Hum Immunol. 2011 May;72(5):431-5. doi: 10.1016/j.humimm.2011.02.014. Epub 2011 Feb 25.

PMID:
21354456
5.

Genetic variation within TLR10 is associated with Crohn's disease in a New Zealand population.

Morgan AR, Lam WJ, Han DY, Fraser AG, Ferguson LR.

Hum Immunol. 2012 Apr;73(4):416-20. doi: 10.1016/j.humimm.2012.01.015. Epub 2012 Feb 2.

PMID:
22342453
6.

Smoking behaviour modifies IL23r-associated disease risk in patients with Crohn's disease.

Doecke JD, Simms LA, Zhao ZZ, Roberts RL, Fowler EV, Croft A, Lin A, Huang N, Whiteman DC, Florin TH, Barclay ML, Merriman TR, Gearry RB, Montgomery GW, Radford-Smith GL.

J Gastroenterol Hepatol. 2015 Feb;30(2):299-307. doi: 10.1111/jgh.12674.

PMID:
24989722
7.

Association analysis of 3p21 with Crohn's disease in a New Zealand population.

Morgan AR, Han DY, Lam WJ, Fraser AG, Ferguson LR.

Hum Immunol. 2010 Jun;71(6):602-9. doi: 10.1016/j.humimm.2010.03.003. Epub 2010 Apr 8.

PMID:
20307617
8.

IL23R R381Q and ATG16L1 T300A are strongly associated with Crohn's disease in a study of New Zealand Caucasians with inflammatory bowel disease.

Roberts RL, Gearry RB, Hollis-Moffatt JE, Miller AL, Reid J, Abkevich V, Timms KM, Gutin A, Lanchbury JS, Merriman TR, Barclay ML, Kennedy MA.

Am J Gastroenterol. 2007 Dec;102(12):2754-61. Epub 2007 Sep 25.

PMID:
17894849
9.

KCNN4 gene variant is associated with ileal Crohn's Disease in the Australian and New Zealand population.

Simms LA, Doecke JD, Roberts RL, Fowler EV, Zhao ZZ, McGuckin MA, Huang N, Hayward NK, Webb PM, Whiteman DC, Cavanaugh JA, McCallum R, Florin TH, Barclay ML, Gearry RB, Merriman TR, Montgomery GW, Radford-Smith GL.

Am J Gastroenterol. 2010 Oct;105(10):2209-17. doi: 10.1038/ajg.2010.161. Epub 2010 Apr 20.

PMID:
20407432
10.

Single nucleotide polymorphisms of deoxyribonuclease I and their expression in Chinese systemic lupus erythematosus patients.

Feng XB, Shen N, Qian J, Sun L, Hua J, Chen SL.

Chin Med J (Engl). 2004 Nov;117(11):1670-6.

PMID:
15569484
11.

Polymorphisms in NFKBIA and ICAM-1 genes in New Zealand Caucasian Crohn's disease patients.

Hong J, Leung E, Fraser AG, Merriman TR, Vishnu P, Krissansen GW.

J Gastroenterol Hepatol. 2007 Oct;22(10):1666-70. Epub 2007 Jun 25.

PMID:
17593226
12.

Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.

Falvey JD, Bentley RW, Merriman TR, Hampton MB, Barclay ML, Gearry RB, Roberts RL.

World J Gastroenterol. 2013 Oct 21;19(39):6656-64. doi: 10.3748/wjg.v19.i39.6656. Review.

13.

Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.

Fragoulis GE, Vakrakou AG, Papadopoulou A, Germenis A, Kanavakis E, Moutsopoulos HM, Manoussakis MN.

J Autoimmun. 2015 Jan;56:12-22. doi: 10.1016/j.jaut.2014.08.004. Epub 2014 Sep 16.

PMID:
25228497
14.

PTPN2 but not PTPN22 is associated with Crohn's disease in a New Zealand population.

Morgan AR, Han DY, Huebner C, Lam WJ, Fraser AG, Ferguson LR.

Tissue Antigens. 2010 Aug;76(2):119-25. doi: 10.1111/j.1399-0039.2010.01493.x. Epub 2010 Apr 13.

PMID:
20403149
15.

Linking genetic susceptibility to Crohn's disease with Th17 cell function: IL-22 serum levels are increased in Crohn's disease and correlate with disease activity and IL23R genotype status.

Schmechel S, Konrad A, Diegelmann J, Glas J, Wetzke M, Paschos E, Lohse P, Göke B, Brand S.

Inflamm Bowel Dis. 2008 Feb;14(2):204-12.

PMID:
18022867
16.

TLR2, TLR4 and TLR9 polymorphisms and Crohn's disease in a New Zealand Caucasian cohort.

Hong J, Leung E, Fraser AG, Merriman TR, Vishnu P, Krissansen GW.

J Gastroenterol Hepatol. 2007 Nov;22(11):1760-6.

PMID:
17914947
17.

IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype.

Lee A, Kanuri N, Zhang Y, Sayuk GS, Li E, Ciorba MA.

PLoS One. 2014 Dec 26;9(12):e115848. doi: 10.1371/journal.pone.0115848. eCollection 2014. Erratum in: PLoS One. 2015;10(7):e0133098.

18.

Influence of HumDN1 VNTR polymorphism on DNASE1 expression in systemic lupus erythematosus and rheumatoid arthritis.

AlFadhli S, Ghanem AA.

Immunol Invest. 2014;43(5):411-23. doi: 10.3109/08820139.2013.864666. Epub 2014 Feb 24.

PMID:
24564745
19.

DNase1 activity in systemic lupus erythematosus patients with and without nephropathy.

Martinez-Valle F, Balada E, Ordi-Ros J, Bujan-Rivas S, Sellas-Fernandez A, Vilardell-Tarres M.

Rheumatol Int. 2010 Nov;30(12):1601-4. doi: 10.1007/s00296-009-1199-6. Epub 2009 Oct 21.

PMID:
19844716
20.

Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand.

Han DY, Fraser AG, Dryland P, Ferguson LR.

Mutat Res. 2010 Aug 7;690(1-2):116-22. doi: 10.1016/j.mrfmmm.2009.09.002. Epub 2009 Sep 12.

PMID:
19751746

Supplemental Content

Support Center